Immunexpress is a pioneer in the analysis of the immune system to rapidly detect sepsis. This technology uses gene expression in the blood with a specific algorithm to detect a patient’s immune response to a pathogen, rather than the traditional approach of trying to identify a causative pathogen, which represents a paradigm shift in sepsis diagnosis. The company’s mission is to develop diagnostic technologies to help clinicians and patients to fight this life-threatening disease. Immunexpress’ offices are in Seattle, Washington.